Drug Controller General Of India Dcgi
Opinion  /  Published 15.08.22

Keep it cool: traditional practices to beat the heat

 Keep it cool Sir — India is no stranger to heat. Naturally, it has a long history, public memory and practices for dealing with it too. Some of those traditional practices to adapt to hea...
By The Telegraph

India  /  Published 04.05.22

Bharat Biotech seeks DCGI nod

Bharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI. Pr...
By Our Bureau, PTI in New Delhi

India  /  Published 07.02.22

Sputnik light vaccine gets nod

Dr Reddy' Laboratories on Monday said the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation in India....
By Our Bureau, PTI in New Delhi

India  /  Published 08.01.22

Dilemma over antiviral drug

Contradictory advice from two wings of the health ministry on whether the antiviral drug molnupiravir should be prescribed to Covid-19 patients could leave doctors and patients befuddled, medical expe...
By G.S. Mudur in New Delhi

India  /  Published 28.12.21

Coming soon: anti-Covid pill

Homegrown pharma majors Sun Pharma, Cipla, Hetero and Torrent on Tuesday announced plans to market their versions of antiviral drug Molnupiravir to treat high-risk adult patients with COVID-19 across ...
By Our Bureau, PTI in New Delhi


India  /  Published 20.12.21

Bharat Biotech seeks nod for phase-3 trials

Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its COVID-19 intranasal vaccine (BBV154) to use as booster dose, sources said on Monday. The...
By Our Bureau, PTI in Hyderabad

India  /  Published 03.09.21

Cobrevax: Nod for trial on kids

Biological E has received approval for conducting phase II/III human clinical trial of Covid-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology...
By Our Bureau, PTI in New Delhi

Opinion  /  Published 24.08.21

Letters to the editor: Nod to three-dose Covid vaccine for kids

Hopeful moment Sir — The Drug Controller General of India’s approval for ZyCoV-D, the three-dose DNA vaccine manufactured by Zydus Cadila, comes as a relief for parents. Children aged 12 ...
By The Telegraph

India  /  Published 20.08.21

First jab for kids gets DCGI nod

Indigenously developed Zydus Cadila COVID-19 vaccine ZyCoV-D has received approval for Emergency Use Authorisation from the Drug Controller General of India and it will be administered to people 12 ye...
By Our Bureau, PTI in New Delhi

India  /  Published 13.08.21

DCGI nod for nasal vaccine trials

The first nasal vaccine against COVID-19, developed by Bharat Biotech, has received regulator's nod for conducting phase 2 and 3 clinical trials, the Department of Biotechnology said on Friday. P...
By Our Bureau, PTI in Hyderabad


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.